☆ 4.7 Letter

Cancer bio-immunotherapy XVIII annual NIBIT-(Italian network for tumor biotherapy) meeting, October 15-16, 2020

CANCER IMMUNOLOGY IMMUNOTHERAPY (2022)

Related references

Note: Only part of the references are listed.

Article Oncology

Dissecting the immune landscape of tumor draining lymph nodes in melanoma with high-plex spatially resolved protein detection

Georgia M. Beasley et al.

Summary: In melanoma patients, the infiltration of CD3 cells in the sentinel lymph nodes varies among patients, with higher infiltration of CD11c and CD3 cells in the SLN tumor region associated with longer overall survival. Expression of DC activation markers such as CD86, HLA-DR, and OX40L on CD11c cells within the SLN tumor region correlates with patient survival, with lowest expression in patients with shorter survival and highest in patients with longer survival. Further studies are needed in a larger cohort to validate these findings.

CANCER IMMUNOLOGY IMMUNOTHERAPY (2021)

Add to Collection

Review Critical Care Medicine

Lung Histopathology in Coronavirus Disease 2019 as Compared With Severe Acute Respiratory Sydrome and H1N1 Influenza A Systematic Review

Lida P. Hariri et al.

Summary: The histopathologic pattern of COVID-19, H1N1 influenza, and SARS patients predominantly involves acute-phase diffuse alveolar damage (DAD), with more frequent pulmonary microthrombi observed in COVID-19 and SARS patients compared to H1N1 influenza. Further research is needed to validate these findings and explore their clinical implications.

CHEST (2021)

Add to Collection

Editorial Material Oncology

B cells and cancer

Victor Engelhard et al.

Summary: Tumor-infiltrating B cells work alongside T cells to combat tumors, controlling tumor growth through various mechanisms and showing a correlation with immunotherapy response.

CANCER CELL (2021)

Add to Collection

Article Immunology

B cells and cancer: To B or not to B?

Wolf Herman Fridman et al.

Summary: Recent studies have suggested that B cells in the tumor microenvironment may play a significant role in presenting tumor-associated antigens to T cells and producing antibodies that enhance antigen presentation, ultimately impacting cancer clinical outcomes. Immune complexes formed by B cells can also have deleterious effects through inflammation, angiogenesis, and immunosuppression via macrophage and complement activation.

JOURNAL OF EXPERIMENTAL MEDICINE (2021)

Add to Collection

Article Multidisciplinary Sciences

Fecal microbiota transplant overcomes resistance to anti-PD-1 therapy in melanoma patients

Diwakar Davar et al.

Summary: The study demonstrated that fecal microbiota transplantation combined with anti-PD-1 therapy can overcome resistance to anti-PD-1 in a subset of PD-1 refractory melanoma patients, leading to clinical benefits. This approach induced changes in the gut microbiome and reprogrammed the tumor microenvironment, ultimately enhancing the efficacy of anti-PD-1 treatment.

SCIENCE (2021)

Add to Collection

Article Multidisciplinary Sciences

Deciphering the state of immune silence in fatal COVID-19 patients

Pierre Bost et al.

Summary: COVID-19 patients show unique immune features, including lung accumulation of naive lymphoid cells, systemic expansion and activation of myeloid cells, and immune suppression. Loss of monocyte-driven and neutrophil-driven immune suppression may lead to fatal outcomes in severe patients. On the other hand, a lung CXCR6(+) effector memory T cell subset may be associated with better prognosis in severe COVID-19 patients.

NATURE COMMUNICATIONS (2021)

Add to Collection

Editorial Material Oncology

Perspectives on COVID-19 and cancer immunotherapy: a review series

Jason D. Goldman et al.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)

Add to Collection

Review Medicine, General & Internal

The Use of Tocilizumab in Patients with COVID-19: A Systematic Review, Meta-Analysis and Trial Sequential Analysis of Randomized Controlled Studies

Alberto Enrico Maraolo et al.

Summary: Tocilizumab (TCZ) may be an important weapon against severe COVID-19, improving the odds of survival for patients. However, further studies are needed to confirm this finding.

JOURNAL OF CLINICAL MEDICINE (2021)

Add to Collection

Review Oncology

Clinical and research applications of multiplexed immunohistochemistry and in situ hybridization

Lisa M. McGinnis et al.

Summary: Novel multiplexing technologies for tissues have greatly impacted basic and translational research by allowing highly multiplexed immunohistochemistry or in situ RNA measurements with objective biomarker quantification and increased sensitivity. These technologies offer unprecedented insights into tissue biology and biomarker science, but implementation requires extensive time and resources.

JOURNAL OF PATHOLOGY (2021)

Add to Collection

Review Pathology

The pathogenic role of epithelial and endothelial cells in early-phase COVID-19 pneumonia: victims and partners in crime

Marco Chilosi et al.

Summary: The understanding of the complex pathogenesis of COVID-19 interstitial pneumonia has been discussed in this article based on biopsies carried out in early/moderate phases and histology data obtained at postmortem analysis. The observations from autopsies cannot fully explain some clinical, radiological and physiopathological features observed in SARS-CoV-2 interstitial pneumonia, suggesting the need for further research to understand the discrepancies.

MODERN PATHOLOGY (2021)

Add to Collection

Article Respiratory System

Covid-19 Interstitial Pneumonia: Histological and Immunohistochemical Features on Cryobiopsies

Claudio Doglioni et al.

Summary: In this study, lung samples from 12 patients with moderate Covid-19 pneumonia were analyzed via transbronchial lung cryobiopsy, revealing early pathological changes such as acute lung injury spots and alveolar type II cell hyperplasia. Additionally, unique endothelial and inflammatory cell phenotypes were observed, providing insights into the pathogenesis of Covid-19 interstitial pneumonia.

RESPIRATION (2021)

Add to Collection

Review Oncology

IL-6 modulation for COVID-19: the right patients at the right time?

Paolo Antonio Ascierto et al.

Summary: The ongoing pandemic caused by SARS-CoV-2 has disrupted the global economy and strained healthcare systems. Initial treatments for severe COVID-19 mainly involve corticosteroids, while there is still a lack of conclusive evidence for managing moderate or mild cases.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)

Add to Collection

Article Multidisciplinary Sciences

Broad betacoronavirus neutralization by a stem helix-specific human antibody

Dora Pinto et al.

Summary: The study identified five monoclonal antibodies from COVID-19 convalescent individuals that cross-react with multiple betacoronavirus spike glycoproteins, with one antibody (S2P6) showing broad neutralization of viruses from three different subgenera. This antibody reduced viral burden in hamsters challenged with SARS-CoV-2 by inhibiting membrane fusion, providing a framework for the design of pan-betacoronavirus vaccines for broad protection.

SCIENCE (2021)

Add to Collection

Article Health Care Sciences & Services

Risk assessment and seroprevalence of SARS-CoV-2 infection in healthcare workers of COVID-19 and non-COVID-19 hospitals in Southern Switzerland

Luca Piccoli et al.

Summary: The study found that up to 10% of HCWs in acute care hospitals in Southern Switzerland have detectable SARS-CoV-2 antibodies. HCWs with exposure to COVID-19 patients have only a slightly higher absolute risk of seropositivity compared to those without, suggesting that the use of PPE and other measures aiming at reducing nosocomial viral transmission are effective. Households contact with known COVID-19 cases represents the highest risk of seropositivity.

LANCET REGIONAL HEALTH-EUROPE (2021)

Add to Collection

Article Medicine, Research & Experimental

Functional characterization of CD4+ T cell receptors crossreactive for SARS-CoV-2 and endemic coronaviruses

Arbor G. Dykema et al.

Summary: Our study confirms the presence of unique memory CD4(+) T cell clones recognizing both SARS-CoV-2 and CCCs. The lower avidity of crossreactive TCRs for SARS-CoV-2 may result in reduced proliferation capacity and impact clinical outcomes in COVID-19 patients. Further research is needed to fully understand the implications of these crossreactive T cell responses.

JOURNAL OF CLINICAL INVESTIGATION (2021)

Add to Collection

Article Microbiology

Microbiota-Propelled T Helper 17 Cells in Inflammatory Diseases and Cancer

Matteo Bellone et al.

MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS (2020)

Add to Collection

Article Multidisciplinary Sciences

B cells are associated with survival and immunotherapy response in sarcoma

Florent Petitprez et al.

NATURE (2020)

Add to Collection

Article Multidisciplinary Sciences

The single-cell pathology landscape of breast cancer

Hartland W. Jackson et al.

NATURE (2020)

Add to Collection

Article Multidisciplinary Sciences

B cells and tertiary lymphoid structures promote immunotherapy response

Beth A. Helmink et al.

NATURE (2020)

Add to Collection

Review Multidisciplinary Sciences

Neoadjuvant checkpoint blockade for cancer immunotherapy

Suzanne L. Topalian et al.

SCIENCE (2020)

Add to Collection

Article Microbiology

Endogenous murine microbiota member Faecalibaculum rodentium and its human homologue protect from intestinal tumour growth

Elena Zagato et al.

NATURE MICROBIOLOGY (2020)

Add to Collection

Article Oncology

Androgen-deprivation therapies for prostate cancer and risk of infection by SARS-CoV-2: a population-based study (N=4532)

M. Montopoli et al.

ANNALS OF ONCOLOGY (2020)

Add to Collection

Article Cell Biology

Pulmonary pathology of early-phase COVID-19 pneumonia in a patient with a benign lung lesion

Zhi Zeng et al.

HISTOPATHOLOGY (2020)

Add to Collection

Article Cell Biology

Postmortem examination of COVID-19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings in lungs and other organs suggesting vascular dysfunction

Thomas Menter et al.

HISTOPATHOLOGY (2020)

Add to Collection

Article Critical Care Medicine

Pathological findings of COVID-19 associated with acute respiratory distress syndrome

Zhe Xu et al.

LANCET RESPIRATORY MEDICINE (2020)

Add to Collection

Article Biotechnology & Applied Microbiology

Multiplex digital spatial profiling of proteins and RNA in fixed tissue

Christopher R. Merritt et al.

NATURE BIOTECHNOLOGY (2020)

Add to Collection

Article Oncology

Coronavirus Disease 2019 in the Perioperative Period of Lung Resection: A Brief Report From a Single Thoracic Surgery Department in Wuhan, People's Republic of China

Yixin Cai et al.

JOURNAL OF THORACIC ONCOLOGY (2020)

Add to Collection

Article Oncology

COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study

Marina Chiara Garassino et al.

LANCET ONCOLOGY (2020)

Add to Collection

Article Medicine, General & Internal

Rapid and Impressive Response to a Combined Treatment with Single-Dose Tocilizumab and NIV in a Patient with COVID-19 Pneumonia/ARDS

Marco Cascella et al.

MEDICINA-LITHUANIA (2020)

Add to Collection

Editorial Material Oncology

Supporting Clinical Decision-Making during the SARS-CoV-2 Pandemic through a Global Research Commitment: The TERAVOLT Experience

Annalisa Trama et al.

CANCER CELL (2020)

Add to Collection

Article Biochemistry & Molecular Biology

Determinants of COVID-19 disease severity in patients with cancer

Elizabeth V. Robilotti et al.

NATURE MEDICINE (2020)

Add to Collection

Article Oncology

Clinical Portrait of the SARS-CoV-2 Epidemic in European Patients with Cancer

David J. Pinato et al.

CANCER DISCOVERY (2020)

Add to Collection

Editorial Material Genetics & Heredity

ACE polymorphisms and COVID-19-related mortality in Europe

Matteo Bellone et al.

JOURNAL OF MOLECULAR MEDICINE-JMM (2020)

Add to Collection

Article Cell & Tissue Engineering

Androgen Signaling Regulates SARS-CoV-2 Receptor Levels and Is Associated with Severe COVID-19 Symptoms in Men

Ryan M. Samuel et al.

CELL STEM CELL (2020)

Add to Collection

Article Medicine, Research & Experimental

Baricitinib restrains the immune dysregulation in patients with severe COVID-19

Vincenzo Bronte et al.

JOURNAL OF CLINICAL INVESTIGATION (2020)

Add to Collection

Review Oncology

ESMO recommendations on microsatellite instability testing for immunotherapy in cancer, and its relationship with PD-1/PD-L1 expression and tumour mutational burden: a systematic review-based approach

C. Luchini et al.

ANNALS OF ONCOLOGY (2019)

Add to Collection

Article Multidisciplinary Sciences

Loss of p53 triggers WNT-dependent systemic inflammation to drive breast cancer metastasis

Max D. Wellenstein et al.

NATURE (2019)

Add to Collection

Review Oncology

Tertiary lymphoid structures in the era of cancer immunotherapy

Catherine Sautes-Fridman et al.

NATURE REVIEWS CANCER (2019)

Add to Collection

Review Oncology

Context-dependent roles of complement in cancer

Lubka T. Roumenina et al.

NATURE REVIEWS CANCER (2019)

Add to Collection

Review Biotechnology & Applied Microbiology

Strategies for enhancing adoptive T-cell immunotherapy against solid tumors using engineered cytokine signaling and other modalities

Thomas Shum et al.

EXPERT OPINION ON BIOLOGICAL THERAPY (2018)

Add to Collection

Article Oncology

The Mutation-Associated Neoantigen Functional Expansion of Specific T Cells (MANAFEST) Assay: A Sensitive Platform for Monitoring Antitumor Immunity

Ludmila Danilova et al.

CANCER IMMUNOLOGY RESEARCH (2018)

Add to Collection

Article Multidisciplinary Sciences

Induction of immunosuppressive functions and NF-kappa B by FLIP in monocytes

Alessandra Fiore et al.

NATURE COMMUNICATIONS (2018)

Add to Collection

Review Immunology

Sex differences in immune responses

Sabra L. Klein et al.

NATURE REVIEWS IMMUNOLOGY (2016)

Add to Collection

© Peeref 2019-2024. All rights reserved.